TE 125.THomo sapiens (Human)Undefined cell line type

Also known as: TE125T, TE-125-T

🤖 AI SummaryBased on 2 publications

Quick Overview

Human fibroblast cell line for cancer research

Detailed Summary

TE 125.T is a human fibroblast cell line with unknown tissue and disease origins. It is used in cancer research, particularly in studies involving genetic diversity and ancestry in cancer cell lines. The cell line's genetic background may influence its utility in understanding cancer disparities and drug response. Researchers utilize this cell line to explore the impact of genetic ancestry on cancer biology and therapeutic outcomes.

Research Applications

Cancer researchGenetic diversity studiesAncestry in cancer cell linesCancer disparitiesDrug response studies

Key Characteristics

Human fibroblastUnknown tissue originUnknown disease originPotential role in understanding cancer disparities
Generated on 6/17/2025

Basic Information

Database IDCVCL_1740
SpeciesHomo sapiens (Human)

Donor Information

Age1
Age CategoryPediatric
SexFemale
Racecaucasian

Disease Information

DiseaseNon-Cancerous
LineageFibroblast
SubtypeFibroblast, Soft Tissue

DepMap Information

Source TypeATCC
Source IDACH-000079_source
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Fibroblasts cell lines misclassified as cancer cell lines.";

de Weck A., Bitter H., Kauffmann A.

bioRxiv 2017:166199-166199(2017).